Mifamurtide
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L03AX15
CAS registry number (Chemical Abstracts Service)
0083461-56-7
Chemical Formula
C59-H109-N6-O19-P
Molecular Weight
1237
Therapeutic Categories
Antineoplastic agent
Immunomodulator
Chemical Name
2-[N-{(2R)-[(2-acetamido-2,3-dideoxy-D-glucopyranos-3-yl)oxy]propanoyl}-L-alanyl-D-isoglutaminyl-L-alanyl)amino]ethyl (2R)-2,3-bis(hexadecanoyloxy)propyl hydrogen phosphate (WHO)
Foreign Names
- Mifamurtidum (Latin)
- Mifamurtid (German)
- Mifamurtide (French)
- Mifamurtida (Spanish)
Generic Names
- Mifamurtide (OS: BAN)
- Cgp-19835A (IS)
- MLV 19835 A (IS)
- MTP-PE (IS)
- Muramyl tripeptide phosphatidyl ethanolamine (IS)
Brand Names
- Mepact
IDM, Latvia; IDM Pharma, Austria; IDM Pharma, Lithuania; IDM Pharma SA, Germany; IDM-Pharma, Norway; Takeda, Spain; Takeda, United Kingdom; Takeda, Italy; Takeda Pharma, Switzerland; Takeda Pharmaceuticals, Sweden
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
